Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

Trichoscopy helped correctly diagnose and treat a scalp and eyebrow fungal infection.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

A 36-year-old woman with worsening hair loss over 10 years was treated with various medications, and after six months, her hair loss did not worsen significantly.

A man with hair loss developed a condition causing scarring and inflammation in both bald and non-bald areas of his scalp.

Colectomy led to hair regrowth in a Crohn's patient with alopecia areata.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Diffuse unpatterned alopecia can affect donor areas, but treatment with finasteride and minoxidil can improve hair density.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Frontal fibrosing alopecia can affect African men and may be underdiagnosed.

Chemotherapy may cause recurring hair loss due to an autoimmune response.

A woman's severe hair loss was caused by scalp psoriasis, not the initially thought condition, and treatment improved her psoriasis but couldn't restore her lost hair.

Infliximab successfully treated a severe hair loss case in Sri Lanka.

A woman's hair loss, resembling an autoimmune condition, improved after treatment, but requires ongoing checks due to potential serious associations.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Topical finasteride formulations can treat hair loss effectively with fewer side effects.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Effective treatment guidelines for frontal fibrosing alopecia are still unclear.

Leflunomide may reduce the risk of alopecia areata, while methotrexate, cyclosporine, and rituximab may increase it.

Covid-19 can cause hair loss due to immune and psychological factors.

Frontal fibrosing alopecia and androgenetic alopecia may be related, with a possible shared cause.

Oral tofacitinib successfully treated total body hair loss in one patient.

Diphencyprone therapy for hair loss can cause vitiligo.

A man had temporary hair loss from radiation during a medical procedure but regrew his hair after treatment with minoxidil lotion.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

A rare skin reaction occurred when a man took paracetamol, causing a new rash in an area already affected by hair loss.